- Scientists at the University of California, San Francisco, have identified two existing cancer drugs that may help lower the risk of Alzheimer's disease.
- Researchers screened over 1,300 candidate drugs, narrowing them down to five that showed potential for reducing Alzheimer's risk in human patients, including two cancer drugs.
- The selected drugs, letrozole (for breast cancer) and irinotecan (for colon and lung cancer), were tested on mice and appeared to improve memory and brain function.
- This finding is significant because developing new drugs for Alzheimer's is extremely costly and time-consuming, whereas repurposing existing ones could accelerate clinical trials.
- The study, published in the medical journal Cell, offers a promising new direction for treatment given that Alzheimer's affects millions and care costs are projected to rise substantially.
IN FULL
These two cancer drugs may help lower your risk of Alzheimer’s disease, study shows
